CARDIFF ONCOLOGY, INC. Temporary Equity, Shares Outstanding
CARDIFF ONCOLOGY, INC. (CRDF) had Temporary Equity, Shares Outstanding of 61.00 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquitySharesOutstanding · last filed 2026-08-11
- 2026-06-30: Temporary Equity, Shares Outstanding 61.00K shares.
- 2026-03-31: Temporary Equity, Shares Outstanding 61.00K shares.
- 2025-12-31: Temporary Equity, Shares Outstanding 61.00K shares.
- 2025-09-30: Temporary Equity, Shares Outstanding 61.00K shares.
| Period end | Temporary Equity, Shares Outstanding | Temporary Equity, Shares Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 61.00K shares 10-Q · filed 2026-08-11 | |
| 2026-03-31 | 61.00K shares 10-Q · filed 2026-05-14 | |
| 2025-12-31 | 61.00K shares 10-Q · filed 2026-08-11 | |
| 2025-09-30 | 61.00K shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 61.00K shares 10-Q · filed 2025-07-29 | |
| 2025-03-31 | 61.00K shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 61.00K shares 10-K · filed 2026-02-24 | |
| 2024-09-30 | 61.00K shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 61.00K shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 60.60K shares 10-Q · filed 2024-05-02 | |
| 2023-12-31 | 61.00K shares 10-K · filed 2025-02-27 | 60.60K shares 10-Q · filed 2024-05-02 |
| 2023-09-30 | 60.60K shares 10-Q · filed 2023-11-02 | |
| 2022-12-31 | 60.60K shares 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |